Humasis205470

Largest holderIncon9.22%$3.7M

Filed holders75% or more, plus insiders

Price and institutional trades

1Y 2Y

$1.64−64.3%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

$3.7M · 2026-09-119.22%+5.93pp

$3.2M · direct 2.17% · indirect 5.70% · 2026-09-117.87%

Direct2.17%
Incon 32.29% → Humasis 9.22%2.98%
Kbio Labs 40.99% → Incon 23.16% → Humasis 9.22%0.88%
Kbio Labs 40.99% → Humasis 4.50%1.84%

$2.7M · direct 4.50% · indirect 2.14% · 2026-09-116.64%

Direct4.50%
Incon 23.16% → Humasis 9.22%2.14%

$2.2M · 2026-09-115.44%

$1.0M · 2026-08-032.59%

$641K · 2026-08-031.58%

1 other related parties$401K0.98%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Companies held by Humasis

Billions$5.1M · 2026-09-0440.05%Kyung NAM Pharm$1.7M · 2026-07-087.55%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-09-11	-	9.01 → 9.22%	+$124K	-	Filing
2026-09-11	2026-09-08	21.12 → 21.33%	+$124K	$2.43	Filing
2026-09-04	2026-09-03	20.77 → 21.12%	+$202K	$2.30	Filing
2026-09-04	-	8.66 → 9.01%	+$202K	-	Filing
2026-08-28	2026-08-27	20.51 → 20.77%	+$148K

Indirect-only holders

$1.0M · indirect2.47%

MiraeING 31.40% → Humasis 2.17%0.68%
MiraeING 31.40% → Incon 32.29% → Humasis 9.22%0.93%
MiraeING 31.40% → Kbio Labs 40.99% → Incon 23.16% → Humasis 9.22%0.27%
MiraeING 31.40% → Kbio Labs 40.99% → Humasis 4.50%0.58%

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Filed	Changed	Holder	Change	Before → after	Amount	Avg buy price
2026-04-23	-			3.29 → 3.29%	−$10M	-	Filing
2026-04-23	2026-04-16			14.84 → 14.84%	-	-	Filing

23 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched